The Japanese experiences with hypoxia-targeting pharmacoradiotherapy: from hypoxic cell sensitisers to radiation-activated prodrugs

Author： Shibamoto Yuta   Sugie Chikao   Ito Masato   Ogino Hiroyuki  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.5, Iss.12, 2004-12, pp. : 2459-2467

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Hypoxia Activated Prodrugs: Factors Influencing Design and Development

By  

Current Medicinal Chemistry, Vol. 22, Iss. 37, 2015-12 ,pp. : 4313-4325

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Prodrugs for Application in Monotherapy Targeting Hypoxia, Tumor-Associated Enzymes, and Receptors

By  

Current Medicinal Chemistry, Vol. 8, Iss. 9, 2001-07 ,pp. : 1093-1122

Bentham Science Publishers

Access to resources Recommend Favorite

From Antioxidant Chelators to Site-Activated Multi-Target Chelators Targeting Hypoxia Inducing Factor, Beta-Amyloid, Acetylcholinesterase and Monoamine Oxidase A/B

By  

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 5, 2012-05 ,pp. : 364-370

Bentham Science Publishers

Access to resources Recommend Favorite

The Intriguing Interplay Between Therapies Targeting the Epidermal Growth Factor Receptor, the Hypoxic Microenvironment and Hypoxia-inducible Factors

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 907-917

Bentham Science Publishers

Access to resources Recommend Favorite

Azo Reductase- Activated Colon- Targeting Prodrugs of Aminosalicylates for Inflammatory Bowel Disease: Preparation, Pharmacokinetic and Pharmacodynamic Profile

By  

Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 12, Iss. 6, 2013-12 ,pp. : 419-432

Bentham Science Publishers

Access to resources Recommend Favorite